Back to Search
Start Over
A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC)
- Source :
- International Journal of Radiation Oncology*Biology*Physics. 105:S19
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Radiation
Durvalumab
biology
business.industry
medicine.disease
CTLA-4
Internal medicine
PD-L1
medicine
biology.protein
Radiology, Nuclear Medicine and imaging
Antibody
Anaplastic thyroid cancer
business
Stereotactic body radiotherapy
Tremelimumab
medicine.drug
Subjects
Details
- ISSN :
- 03603016
- Volume :
- 105
- Database :
- OpenAIRE
- Journal :
- International Journal of Radiation Oncology*Biology*Physics
- Accession number :
- edsair.doi...........7c4ee1b0b8525d524b6c52869a481b9b